Lannett Stock Up 6.3 %
Shares of Lannett stock opened at $0.52 on Wednesday. The stock has a market capitalization of $22.38 million, a P/E ratio of -0.09 and a beta of 0.94. The company has a 50-day simple moving average of $0.47 and a 200 day simple moving average of $0.53. Lannett has a 12-month low of $0.39 and a 12-month high of $2.16.
Lannett (NYSE:LCI – Get Rating) last announced its quarterly earnings data on Wednesday, November 2nd. The company reported ($0.42) EPS for the quarter, beating analysts’ consensus estimates of ($0.46) by $0.04. The firm had revenue of $75.08 million during the quarter, compared to the consensus estimate of $68.23 million. On average, equities analysts anticipate that Lannett will post -1.61 earnings per share for the current year.
Institutional Trading of Lannett
Lannett Company Profile
Lannett Company, Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages.
- Get a free copy of the StockNews.com research report on Lannett (LCI)
- Power Integrations Stock Can Power Your Portfolio
- Don’t Chase Walmart Higher, Wait For Extra Low Prices
- Home Depot Results (and Institutions) Are A Catalyst For Lowe’s?
- Three Penny Stocks Making Big Moves In November
- Agilent Remains In Buy Range Ahead Of Next Week’s Q4 Report
Receive News & Ratings for Lannett Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lannett and related companies with MarketBeat.com's FREE daily email newsletter.